Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (12) , 1977-1980
- https://doi.org/10.1016/s0959-8049(98)00235-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 200 Gemcitabine in the treatment of advanced non-small-cell lung cancer: A phase II trialLung Cancer, 1997
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)Annals of Oncology, 1995
- A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancerLung Cancer, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Reporting results of cancer treatmentCancer, 1981